ISB Nabs $8M for Cancer Genome

Luke Timmerman11/10/09

The Institute for Systems Biology, a Seattle-based nonprofit research center, said today it has secured an $8 million grant from the National Institutes of Health as part of The Cancer Genome Atlas, an effort to identify new targets for cancer drugs based on deeper genomic understanding. ISB professor Ilya Shmulevich is the co-primary investigator on the grant along with Wei Zhang of M.D. Anderson Cancer Center in Houston. Other centers receiving federal grants for the cancer genome include the Broad Institute of Harvard and MIT; Lawrence Berkeley National Laboratory; and Memorial Sloan-Kettering Cancer Center.

Luke Timmerman is the National Biotech Editor of Xconomy, and the Editor of Xconomy Seattle. E-mail him at ltimmerman@xconomy.com or follow him on Twitter at twitter.com/ldtimmerman.